Top Story

Kallikrein markers improve high-grade prostate cancer detection, reduce unnecessary biopsies

May 25, 2015

A statistical model using kallikrein markers better predicted high-grade prostate cancer in men with elevated PSA levels and reduced unnecessary biopsies compared with PSA level and age alone, according to the results of a prospective analysis.

“Risk of death from prostate cancer is strongly associated with levels of PSA in blood measured in middle-aged men,” Hans Lilja, MD, PhD, of Memorial Sloan Kettering Cancer Center, and colleagues wrote. “Evidence from randomized screening trials in Europe shows that PSA-based screening can reduce deaths from prostate cancer, but also leads to overdiagnosis and the risk of overtreatment among elderly men with a limited life expectancy.”

Enrollment open for phase 2 trial of Melphalan/HDS for HCC

May 25, 2015
Delcath Systems, Inc. announced the intrahepatic cholangiocarcinoma study cohort of its global phase 2 trial of Melphalan/HDS therapy for the treatment of unresectable…
Cover StoryPublication Exclusive

Despite promise, ‘maximum potential’ of precision medicine yet to be reached

HemOnc Today, May 25, 2015
Precision medicine has garnered tremendous public attention since President Barack Obama established it as a national priority during his State of the Union address.The…
David A. Williams, MD Association News

ASH announces training program participants

May 24, 2015
ASH and the European Hematology Association released the names of 20 early-career hematologists who are participating in the 2015 Translational Research in Hematology…
Martin McMahon, PhD Institution Notes

Cancer institute appoints senior director

May 23, 2015
Martin McMahon, PhD, has been appointed professor in the department of dermatology and senior director of pre-clinical translation at Huntsman Cancer Institute at the…
More News Headlines »
CME CNE
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
VIDEO: Updates in prostate cancer treatment options

VIDEO: Updates in prostate cancer treatment options

May 5, 2015
Robert S. DiPaola, MD, director of Rutgers Cancer Institute of New Jersey, discusses various forms of prostate cancer…
More »
CME
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
morganatic-roan